US5980917A - Oil-in-water type cosmetic composition containing retinoids stabilized by a liquidcrystal - Google Patents
Oil-in-water type cosmetic composition containing retinoids stabilized by a liquidcrystal Download PDFInfo
- Publication number
- US5980917A US5980917A US08/956,291 US95629197A US5980917A US 5980917 A US5980917 A US 5980917A US 95629197 A US95629197 A US 95629197A US 5980917 A US5980917 A US 5980917A
- Authority
- US
- United States
- Prior art keywords
- polyglyceryl
- alkylglucose
- cosmetic composition
- oil
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 16
- 239000004094 surface-active agent Substances 0.000 claims abstract description 22
- 230000007704 transition Effects 0.000 claims abstract description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 38
- 235000020944 retinol Nutrition 0.000 claims description 20
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 19
- 229960003471 retinol Drugs 0.000 claims description 19
- 239000011607 retinol Substances 0.000 claims description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 16
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 9
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 9
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 235000006708 antioxidants Nutrition 0.000 claims description 8
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 8
- 150000002191 fatty alcohols Chemical class 0.000 claims description 8
- 230000003078 antioxidant effect Effects 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000004492 retinoid derivatives Chemical class 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims description 4
- 229930002945 all-trans-retinaldehyde Natural products 0.000 claims description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 3
- 230000002207 retinal effect Effects 0.000 claims description 3
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 claims description 3
- 229930002330 retinoic acid Natural products 0.000 claims description 3
- 229960001727 tretinoin Drugs 0.000 claims description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 3
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229920003169 water-soluble polymer Polymers 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 2
- 230000001804 emulsifying effect Effects 0.000 claims 2
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 15
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- FRGAIZLZPOROJH-BKIJVIAGSA-N [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-3-[2-hydroxy-3-(2-hydroxy-3-octadecanoyloxypropoxy)propoxy]propoxy]oxan-2-yl]methyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COCC(O)CO[C@H]1O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@H]1O FRGAIZLZPOROJH-BKIJVIAGSA-N 0.000 description 7
- 229940108325 retinyl palmitate Drugs 0.000 description 7
- 235000019172 retinyl palmitate Nutrition 0.000 description 7
- 239000011769 retinyl palmitate Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000446313 Lamella Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940082500 cetostearyl alcohol Drugs 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000003077 polyols Chemical group 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to an oil-in-water type cosmetic composition containing retinoids. More particularly it relates to an oil-in-water type cosmetic composition containing retinoids stabilized within a core of a liquidcrystal formed by a surfactant having a high phase transition temperature and a bulky structure.
- retinoids are very effective in recovering the skin from various damages caused by wrinkles, roughness, drying or abnormal peeling(U.S. Pat. No. 4,603,146 and U.S. Pat. No. 4,877,805).
- Retinoids include retinol, retinal, retinyl palmitate, retinyl acetate, retinoic acid and the like. Among them, in consideration of efficacy and safety to the skin, retinol is the most compatible for the skin.
- Retinol and its derivatives have an outstanding effect in preventing the formation of skin wrinkles. However, they are easily oxidized in an air or in an aqueous solution, and loss their stability and physiological activities. Due to their instability, there has been a limit in incorporating retinol into cosmetic formulations.
- retinoids can be stabilized to some extent by these antioxidants, excessive use of antioxidant may cause skin irritation. And, there is a limit in stabilizing retinoids without blocking contact with water which is present in a cosmetic base. Further, since instability of retinoids may be accelerated by oxygen attack through the medium of aqueous solution, many research for stabilization of retinoids are being conducted in a structural aspect of emulsion system itself.
- the present inventors have conducted extensive studies in order to stabilize retinoids in an O/W type emulsion rendering good feel to the skin.
- liquidcrystals In general, a combination of surfactants, fatty alcohols and polyols forms liquidcrystals. However, since this liquidcrystal has flexibility and permeability, material transfer between a core and an outer may occur through liquidcrystal film, and thereby it is difficult to stabilize retinoids of a core.
- the present inventors found that use of surfactants having a high phase transition temperature and a bulky structure forms a strip-shape, wide and dense liquidcrystal film and thereby material transfer between a core and an outer can be remarkably reduced. They guessed active ingredients of a core to be trapped and fixed within a lamella structure of a thick and dense liquidcrystal film. The present invention was accomplished based on this finding.
- an object of this invention is to provide a method for stabilizing retinoids in an O/W type cosmetic composition.
- Another object of this invention is to provide an O/W type cosmetic composition containing retinoids without appreciable loss of its activity.
- Still another object of this invention is to provide a method for preparing said O/W type cosmetic composition.
- FIG. 1 is a photograph showing the formation of SWLC in Example 1.
- the present invention provides an oil-in-water type(O/W type) cosmetic composition wherein retinoid as an active ingredient is contained within a core of a liquidcrystal formed by a combination of 0.5 ⁇ 20% by weight of a surfactant having a phase transition temperature of 45° C. or higher, 0.1 ⁇ 10% by weight of fatty alcohol and 0.1 ⁇ 10% by weight of cholesterol, based on a total weight of the composition.
- the present invention provides an O/W type cosmetic composition containing one or more retinoids selected from a group consisting of retinol, retinal, retinoic acid and its esters, in an amount of 100 ⁇ 50,000 IU per 1 g of composition.
- the O/W type cosmetic composition according to the present invention will be described in more detail.
- the present invention is provided for stabilizing retinoids in an O/W type cosmetics, and is characterized in that it contains a surfactant having a phase transition temperature of 45° C. or higher as a liquidcrystal-forming material, together with fatty alcohol and cholesterol.
- the surfactant may be employed alone or in combination with one or more other surfactants.
- Specific examples are NIKKOMULESE-41 (polyglyceryl(10) pentastearate-behenyl alcohol-sodium stearoyl lactoylate) available by Nikko Chemical Co., Ltd., EMULGADE PL-1618 (cetearyl alcohol-cetearyl polyglucose) available by Henkel Co., Ltd., and TEGOCARE 450 (polyglyceryl(3)-methylglucose distearate) available by Goldschmidts Co., Ltd.
- This surfactant may be employed in an amount of 0.5 ⁇ 20% by weight based on a total weight of the composition.
- This surfactant having 45° C. or higher phase transition temperature together with fatty alcohol and cholesterol is present in the form of lamella in small portion of water and forms a thick and dense liquidcrystal film surrounding oily materials.
- the liquidcrystal film formed in the present invention has a wide and rigid strip-shape as shown in FIG. 1. So, in this application, it is named as SWLC(Super Wide LiquidCrystal).
- the method according to the present invention comprises following steps:
- a combination of the above-described surfactant, fatty alcohol and cholesterol is mixed and emulsified in small portion of distilled water at a temperature of about 70° C., and then retinoids as a core are added thereto. Then, resulting mixture is cooled to a room temperature to give a SWLC base.
- Aqueous part is emulsified by using the same surfactants as that for forming liquidcrystals, and then is cooled to a room temperature. Then, water-soluble polymer is added thereto to give a gel-type base.
- the SWLC base of the step (1) is added to the gel-type base of the step (2), and then mixed to give an O/W type cosmetics.
- the surfactants constructing the liquidcrystals can be prevented from sudden releasing into the gel-type base. That is, SWLC surrounding a core containing retinoids maintains compact and dense lamella structure at a room temperature which is lower than the phase transition temperature of the surfactant. This compact lamella structure is expected to block the transfer of components between a core and an outer.
- retinoid contained in the cosmetic composition of the present invention has its activity to about 82%, during a storage of 4 weeks, under an environment of 45° C.
- the composition according to the present invention may contain an antioxidant such as BHT and BHA, and a chelating reagent such as EDTA.
- the SWLC base of the step (1) was added to the gel-type base of the step (2), and then stirred to give an O/W type composition.
- retinol can be stabilized and maintain its activity within a SWLC formed by surfactants having 45° C. or higher phase transition temperature together with fatty alcohols and cholesterols.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
__________________________________________________________________________
Comparative Examples 1˜7
Comparative Examples
Materials 1 2 3 4 5 6 7
__________________________________________________________________________
1. Stearic acid 1.0 1.0 1.0 1.0 1.0 1.0 1.0
2. Cetostearyl alcohol -- -- -- -- 1.5 -- 1.5
3. Liquid paraffin 3.0 3.0 3.0 3.0 3.0 3.0 3.0
4. Monostearic sorbitan 0.3 0.3 0.3 0.3 0.3 0.3 0.3
5. Monostearic polyoxyethylene(20) sorbitan 3.0 3.0 3.0 3.0 3.0 3.0 3.0
6. Caprylic/capric triglyceride 5.0 5.0 5.0 5.0 5.0 5.0 5.0
*7. NIKKOMULESE-41 -- -- -- -- -- -- --
*8. EMULGADE PL-1618 -- -- -- -- -- -- --
*9. TEGOCARE 450 -- -- -- -- -- -- --
10. Cholesterol -- -- -- -- 0.5 -- 0.5
11. Cyclomethicone 1.5 1.5 1.5 1.5 1.5 1.5 1.5
12. Preservative q.s. q.s. q.s. q.s. q.s. q.s. q.s.
13. BHT -- -- 0.05 0.05 0.05 0.05 0.05
14. BHA -- -- 0.05 0.05 0.05 0.05 0.05
15. Distilled water 8.0 8.0 8.0 8.0 8.0 8.0 8.0
16. Concentrated glycerine 15.0 15.0 15.0 15.0 15.0 15.0 15.0
17. NIKKOMULESE-41 -- -- --
0.2 -- 0.2 0.2
18. EMULGADE PL-1618 -- -- -- 0.8 -- 0.8 0.8
19. TEGOCARE 450 -- -- -- 0.1 -- 0.1 0.1
20. Cetostearyl alcohol 0.3 0.3 0.3 0.3 0.3 0.3 0.3
21. EDTA-2Na -- 0.05 0.05 0.05 0.05 0.05 0.05
22. Distilled water to 100 to 100 to 100 to 100 to 100 to 100 to 100
23. KOH q.s. q.s. q.s. q.s.
q.s. q.s. q.s.
24. Hyaruronic acid extracts 0.5 0.5 0.5 0.5 0.5 0.5 0.5
25. Carboxyvinyl polymer 0.12 0.12 0.12 0.12 0.12 0.12 0.12
26. Perfume q.s. q.s. q.s.
q.s. q.s. q.s. q.s.
*27. Retinol(10%) 1.0 1.0 1.0 1.0 1.0 -- --
*28. Retinyl palmitate(10%) -- -- -- -- -- 0.5 0.5
__________________________________________________________________________
(Note)
*7. NIKKOMULESE41 (manufactured by Nikko Chemical Co., Ltd.):
Polyglyceryl(10) pentastearate behenyl alcoholsodium stearoyl lactoylate
*8. EMULGADE PL1618 (manufactured by Henkel Co., Ltd.): Cetearyl
alcoholcetearyl polyglucose
*9. TEGOCARE 450 (manufactured by Goldschmidts Co., Ltd.):
Polyglyceryl(3)methylglucose distearate
*27. Retinol(10%): all trans form of retinol 10% solution in
caprylic/capric triglyceride
*28. Retinyl palmitate(10%): 10% of retinol palmitate in caprylic/capric
triglyceride
__________________________________________________________________________
Examples 1˜7
Examples
Materials 1 2 3 4 5 6 7
__________________________________________________________________________
1. Stearic acid 1.0 1.0 1.0 1.0 1.0 1.0 1.0
2. Cetostearyl alcohol 1.5 1.5 1.5 1.5 1.5 -- 1.5
3. Liquid paraffin 3.0 3.0 3.0 3.0 3.0 3.0 3.0
4. Monostearic sorbitan 0.3 0.3 0.3 0.3 0.3 0.3 0.3
5. Monostearic polyoxyethylene(20) sorbitan 3.0 3.0 3.0 3.0 3.0 3.0 3.0
6. Caprylic/capric triglyceride 5.0 5.0 5.0 5.0 5.0 5.0 5.0
*7. NIKKOMULESE-41 0.8 0.8 0.8 3.0 -- -- 1.0
*8. EMULGADE PL-1618 3.0 3.0 3.0 -- 3.0 -- 1.0
*9. TEGOCARE 450 0.2 0.2 0.2 -- -- 3.0 1.0
10. Cholesterol 0.5 0.5 0.5 0.5 0.5 0.5 0.5
11. Cyclomethicone 1.5 1.5 1.5 1.5 1.5 1.5 1.5
12. Preservative q.s. q.s. q.s. q.s. q.s. q.s. q.s.
13. BHT -- 0.05 0.05 0.05 0.05 0.05 0.05
14. BHA -- 0.05 0.05 0.05 0.05 0.05 0.05
15. Distilled water 8.0 8.0 8.0 8.0 8.0 8.0 8.0
16. Concentrated glycerine 15.0 15.0 15.0 15.0 15.0 15.0 15.0
17. NIKKOMULESE-41 0.2 0.2
0.2 0.2 0.2 0.2 0.2
18. EMULGADE PL-1618 0.8 0.8 0.8 0.8 0.8 0.8 0.8
19. TEGOCARE 450 0.1 0.1 0.1 0.1 0.1 0.1 0.1
20. Cetostearyl alcohol 0.3 0.3 0.3 0.3 0.3 0.3 0.3
21. EDTA-2Na -- 0.05 0.05 0.05 0.05 0.05 0.05
22. Distilled water to 100 to 100 to 100 to 100 to 100 to 100 to 100
23. KOH q.s. q.s. q.s. q.s.
q.s. q.s. q.s.
24. Hyaruronic acid extracts 0.5 0.5 0.5 0.5 0.5 0.5 0.5
25. Carboxyvinyl polymer 0.12 0.12 0.12 0.12 0.12 0.12 0.12
26. Perfume q.s. q.s. q.s.
q.s. q.s. q.s. q.s.
*27. Retinol(10%) 1.0 1.0 -- 1.0 1.0 1.0 1.0
*28. Retinyl palmitate(10%) -- -- 0.5 -- -- 0.5 --
__________________________________________________________________________
(Note)
*7. NIKKOMULESE41 (manufactured by Nikko Chemical Co., Ltd.):
Polyglyceryl(10) pentastearate behenyl alcoholsodium stearoyl lactoylate
*8. EMULGADE PL1618 (manufactured by Henkel Co., Ltd.): Cetearyl
alcoholcetearyl polyglucose
*9. TEGOCARE 450 (manufactured by Goldschmidts Co., Ltd.):
Polyglyceryl(3)methylglucose distearate
*27. Retinol(10%): all trans form of retinol 10% solution in
caprylic/capric triglyceride
*28. Retinyl palmitate(10%): 10% of retinol palmitate in caprylic/capric
triglyceride
TABLE 1
__________________________________________________________________________
1 2 3 4 5 6 7
__________________________________________________________________________
Comparative Examples
Formation of SWLC
X X X X X X X
(not formed)
Maintenance of activity 9% 18% 24% 24% 28% 28% 32%
(45° C., for 4 weeks)
Examples
Formation of SWLC
◯
◯
◯
Δ Δ
Δ
◯
(formed) (partially formed)
Maintenance of activity 82% 87% 91% 42% 72% 43% 65%
(45° C., for 4 weeks)
__________________________________________________________________________
Claims (6)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR97-47231 | 1997-09-12 | ||
| KR1019970047231A KR100258674B1 (en) | 1997-09-12 | 1997-09-12 | A method for preparation of oil-in-water type cosmetic containing retinoids having improved stability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US5980917A true US5980917A (en) | 1999-11-09 |
Family
ID=19521282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/956,291 Expired - Lifetime US5980917A (en) | 1997-09-12 | 1997-10-23 | Oil-in-water type cosmetic composition containing retinoids stabilized by a liquidcrystal |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US5980917A (en) |
| JP (1) | JP3447935B2 (en) |
| KR (1) | KR100258674B1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1236462A1 (en) * | 2001-02-28 | 2002-09-04 | Neopharm Co., Ltd. | Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
| FR2829391A1 (en) * | 2001-09-07 | 2003-03-14 | Coreana Cosmetics Co Ltd | COSMETIC COMPOSITION CONTAINING FULLY ENCAPSULATED RETINOL |
| US20030232091A1 (en) * | 2002-06-17 | 2003-12-18 | Adi Shefer | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof |
| US20180161259A1 (en) * | 2016-12-13 | 2018-06-14 | The Procter & Gamble Company | Stable Personal Care Compositions Containing a Retinoid |
| US11197826B2 (en) * | 2015-12-23 | 2021-12-14 | Novartis Ag | Oil-in-water emulsions including retinoic acid |
| WO2022006032A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic composition having retinol |
| WO2022006038A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic composition having stabilized retinol |
| WO2022006054A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic compositions having stabilized retinol |
| FR3113834A1 (en) * | 2020-09-07 | 2022-03-11 | L'oreal | COSMETIC COMPOSITIONS COMPRISING STABILIZED RETINOL |
| FR3113833A1 (en) * | 2020-09-08 | 2022-03-11 | L'oreal | COSMETIC COMPOSITION CONTAINING RETINOL |
| FR3114025A1 (en) * | 2020-09-11 | 2022-03-18 | L'oreal | COSMETIC COMPOSITION COMPRISING STABILIZED RETINOL |
| US11865197B2 (en) * | 2020-06-30 | 2024-01-09 | L'oreal | Cosmetic compositions having stabilized retinol |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101011719B1 (en) * | 2002-03-29 | 2011-01-28 | 가부시키가이샤 코세 | Cosmetics |
| JP4731301B2 (en) * | 2005-12-05 | 2011-07-20 | 株式会社ヤクルト本社 | Moisturizer and cosmetics containing the same |
| JP2010001218A (en) * | 2006-10-27 | 2010-01-07 | Taisho Pharmaceutical Co Ltd | Composition for skin external use and skin regeneration promoter |
| JP5964176B2 (en) * | 2012-08-21 | 2016-08-03 | ポーラ化成工業株式会社 | Skin external composition |
| KR102105210B1 (en) | 2012-11-26 | 2020-04-27 | 코웨이 주식회사 | Cosmetic composition of oil in water emulsion stabilized retinoids derivative |
| JP2014198706A (en) * | 2013-03-12 | 2014-10-23 | 御木本製薬株式会社 | Cosmetic preparation |
| KR102134931B1 (en) | 2013-12-27 | 2020-07-16 | 코웨이 주식회사 | Cosmetic composition comprising transparent and visible spherical particles |
| JP6752485B2 (en) * | 2016-08-16 | 2020-09-09 | 株式会社希松 | Liquid crystal composition and cosmetics containing the liquid crystal composition |
| KR20250080815A (en) | 2023-11-28 | 2025-06-05 | 코스맥스 주식회사 | Cosmetic composition containing stabilized retinol |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
| US4466805A (en) * | 1977-05-20 | 1984-08-21 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Hairdyeing composition and method |
| US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
| US4826828A (en) * | 1985-04-22 | 1989-05-02 | Avon Products, Inc. | Composition and method for reducing wrinkles |
| US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| US5658575A (en) * | 1993-09-07 | 1997-08-19 | L'oreal | Cosmetic or dermatological composition comprising an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4999348A (en) | 1987-12-11 | 1991-03-12 | Estee Lauder Inc. | Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
-
1997
- 1997-09-12 KR KR1019970047231A patent/KR100258674B1/en not_active Expired - Fee Related
- 1997-10-23 US US08/956,291 patent/US5980917A/en not_active Expired - Lifetime
- 1997-10-30 JP JP31288897A patent/JP3447935B2/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4466805A (en) * | 1977-05-20 | 1984-08-21 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Hairdyeing composition and method |
| US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
| US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
| US4826828A (en) * | 1985-04-22 | 1989-05-02 | Avon Products, Inc. | Composition and method for reducing wrinkles |
| US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| US5658575A (en) * | 1993-09-07 | 1997-08-19 | L'oreal | Cosmetic or dermatological composition comprising an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1236462A1 (en) * | 2001-02-28 | 2002-09-04 | Neopharm Co., Ltd. | Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
| EP1370241A4 (en) * | 2001-02-28 | 2005-01-26 | Neopharm Co Ltd | Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same |
| FR2829391A1 (en) * | 2001-09-07 | 2003-03-14 | Coreana Cosmetics Co Ltd | COSMETIC COMPOSITION CONTAINING FULLY ENCAPSULATED RETINOL |
| US20030232091A1 (en) * | 2002-06-17 | 2003-12-18 | Adi Shefer | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof |
| US11197826B2 (en) * | 2015-12-23 | 2021-12-14 | Novartis Ag | Oil-in-water emulsions including retinoic acid |
| US20180161259A1 (en) * | 2016-12-13 | 2018-06-14 | The Procter & Gamble Company | Stable Personal Care Compositions Containing a Retinoid |
| CN110062618A (en) * | 2016-12-13 | 2019-07-26 | 宝洁公司 | Stabilization personal care composition comprising retinoid |
| US10493009B2 (en) * | 2016-12-13 | 2019-12-03 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
| WO2022006032A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic composition having retinol |
| WO2022006038A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic composition having stabilized retinol |
| WO2022006054A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic compositions having stabilized retinol |
| CN115803000A (en) * | 2020-06-30 | 2023-03-14 | 莱雅公司 | Cosmetic composition with stabilized retinol |
| US11865197B2 (en) * | 2020-06-30 | 2024-01-09 | L'oreal | Cosmetic compositions having stabilized retinol |
| FR3113834A1 (en) * | 2020-09-07 | 2022-03-11 | L'oreal | COSMETIC COMPOSITIONS COMPRISING STABILIZED RETINOL |
| FR3113833A1 (en) * | 2020-09-08 | 2022-03-11 | L'oreal | COSMETIC COMPOSITION CONTAINING RETINOL |
| FR3114025A1 (en) * | 2020-09-11 | 2022-03-18 | L'oreal | COSMETIC COMPOSITION COMPRISING STABILIZED RETINOL |
Also Published As
| Publication number | Publication date |
|---|---|
| KR100258674B1 (en) | 2000-07-01 |
| JP3447935B2 (en) | 2003-09-16 |
| KR19990025563A (en) | 1999-04-06 |
| JPH1179929A (en) | 1999-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5980917A (en) | Oil-in-water type cosmetic composition containing retinoids stabilized by a liquidcrystal | |
| US6342238B1 (en) | Organogel comprising an oxidation-sensitive hydrophilic compound, and uses thereof, in particular cosmetic uses | |
| Liebler et al. | Antioxidant protection of phospholipid bilayers by alpha-tocopherol. Control of alpha-tocopherol status and lipid peroxidation by ascorbic acid and glutathione. | |
| EP2193778B1 (en) | Skin care composition | |
| CN1085523C (en) | Preparation for epidermis and process for its preparation | |
| AU743528B2 (en) | Cosmetic compositions | |
| US6020367A (en) | Supersaturated ascorbic acid solutions | |
| US6210693B1 (en) | Oil-in-water type emulsified composition | |
| KR19990088408A (en) | Stable W/O/W emulsion and its use as cosmetic and/or dermatological composition | |
| AU570639B2 (en) | Corticoid topical formulation | |
| JP2007238625A (en) | Stabilized ascorbic acid solution; use thereof; process for its preparation; and formulation comprising the same | |
| WO1995026707A1 (en) | Dialkyl ether-containing micro-emulsions | |
| EP1370241A1 (en) | Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same | |
| US6113928A (en) | Skin cosmetic composition containing retinal | |
| US6150422A (en) | Stable gelled composition containing lipophilic active agents sensitive to oxygen and/or water | |
| KR102448054B1 (en) | Hair dye composition and method for preparing the same | |
| CN107028774B (en) | Heat stable suspension cosmetic composition | |
| US5358716A (en) | Pharmaceutical composition for topical application containing dithranol and preparation process | |
| KR102646279B1 (en) | A composition having improved emulsion stability comprising hydroquinone | |
| JP3192234B2 (en) | External preparation for skin | |
| JP3313148B2 (en) | External preparation for skin | |
| JPS602903B2 (en) | Preparation method of multiphase emulsion | |
| CN114828839A (en) | Vitamin A and vitamin C combinations with enhanced stability | |
| JPH0899827A (en) | Skin external agent | |
| JPS61207326A (en) | Skin treating composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: PACIFIC CORPORATION, KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KANG, HAK HEE;CHO, JUN CHUL;KIM, JUNG SU;AND OTHERS;REEL/FRAME:008870/0670 Effective date: 19971017 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 12 |